Latest presentation
Investor R&D Day 2023
Investor R&D Day 2023
Jefferies London Healthcare Conference
Quarter Ended Jun 30, 2023
For fiscal year ending Dec 31, 2022
Sign up today and receive company updates straight to your inbox.
Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Biomedical innovation is dependent on a reliable supply of reagents in the fields of nucleic acid production, biologics safety testing and protein detection. From inventive startups to many of the world's leading biopharma, vaccine, diagnostics and cell and gene therapy companies, customers turn to Maravai to address their complex discovery challenges and help them streamline and scale from research through clinical trials to commercialization.
Maravai holds a number of patents and offers innovative products and services including CleanCap®, CleanAmp®, GMPLink™, Antibody Affinity Extraction™ (AAE™), EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV®, Sterling™, Glen Pak™, Glen Gel-Pak™, and Poly-Pak™.
Maravai's portfolio companies are ISO-9001:2015 certified and have earned hundreds of thousands of citations in peer-reviewed scientific publications.
Maravai LifeSciences Holdings, Inc.
10770 Wateridge Circle
Suite 200
San Diego, CA 92121
United States
ir@maravai.com
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, New York, 11219
United States
T: 800-937-5449
help@astfinancial.com
https://www.astfinancial.com/contact-us